EUROBIO-SCIENTIFIC news, videos and press releases
For more news please use our advanced search feature.
EUROBIO-SCIENTIFIC - More news...
EUROBIO-SCIENTIFIC - More news...
- Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
- EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS
- EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
- EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
- Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023
- Eurobio Scientific: GenDx reduces organ matching time to 3 hours
- EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023
- Eurobio Scientific : 2022 ANNUAL RESULTS - Very strong performance and strengthening of the Core Business
- Eurobio Scientific formalises the appointment of Anne-Sophie Hérelle as Group CFO
- EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF GENDX, INTERNATIONAL HLA DIAGNOSTICS SPECIALIST
- EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENDX, INTERNATIONAL HLA DIAGNOSTICS SPECIALIST
- Eurobio Scientific launches 2 new proprietary tests for the diagnosis of new variants of SARS-CoV-2 and Monkeypox
- Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV
- EUROBIO SCIENTIFIC: CLOSING OF THE STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM
- Eurobio Scientific: CE mark for new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2
- EUROBIO SCIENTIFIC: MAINTAINING HIGH LEVEL RESULTS IN 2021
- EUROBIO SCIENTIFIC: STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM
- EUROBIO SCIENTIFIC LAUNCHES THE EXCLUSIVE DISTRIBUTION OF THE FIRST SALIVA SELF-TEST FOR HIV TESTING IN FRANCE
- Eurobio Scientific Makes a Minority Investment in Usense, a Start-Up Developping a Mobile in Vitro Medical Device for Urianalysis
- Eurobio Scientific Receives a $430,000 Milestone Payment From Allergan
- Eurobio Scientific: FIRST HALF TURNOVER REACHES € 95.7 MILLION, A 54% INCREASE
- Eurobio Scientific launches its COVID antigen self-test
- Eurobio Scientific offers a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations of interest
- Eurobio Scientific: EXCEPTIONAL 2020 TURNOVER OF € 189 MILLION (+ 220%)
- Eurobio Scientific expands its range of COVID-19 tests with an antigenic rapid test
- Eurobio Scientific : 2020 HALF-YEAR RESULTS
- Eurobio Scientific launches a first rapid diagnostic test for the detection of the SARS CoV-2 virus antigen
- Eurobio Scientific: Very Strong Growth of Business During the First Half of 2020
- Eurobio Scientific expands into Switzerland, Germany, Austria and Benelux by acquiring the diagnostic company TECOmedical AG
- Eurobio Scientific: Eurobio Scientific's proprietary PCR test confirmed as part of the fight against COVID-19